Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
09/30/14 Erytech ERY-ASP for Acute Lymphocytic Leukemia (ALL) Subscribers Only Subscribers Only     Subscribers Only
09/30/14 Regeneron (REGN) Dupilumab for Nasal Polyposis Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Jacobus 3,4-DAP (Jacobus) for Lambert-Eaton Myasthenic Syndrome (LEMS) Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Catalyst Pharmaceuticals (CPRX) Firdapse for Lambert-Eaton Myasthenic Syndrome (LEMS) Subscribers Only Subscribers Only     Subscribers Only
09/29/14 Roche (ROG:VX) Cobimetinib for Melanoma Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
10/01/14 Subscribers Only Subscribers Only Patent - Expiration
10/01/14 Subscribers Only Subscribers Only Other
10/01/14 Subscribers Only Subscribers Only Other
10/01/14 Subscribers Only Subscribers Only Other
10/02/14 Subscribers Only Subscribers Only Progress Update - Development Review